ArticleJournal of pharmaceutical policy and practice2026
The impact of China's National Drug Centralized Procurement Policy on pharmaceutical firm innovation: evidence from a staggered difference-in-differences analysis.
Ying Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.